The 2020 Top 10 Orthopedic Device Companies

The 2023 version is ready and live online. Click here to review the latest Top Companies list!

It may have lacked the blockbuster tone of years past, but the orthopedic industry’s dealmaking exploits in 2019 could hardly be considered a bust. Alliances and acquisitions continued to shape the market, albeit a bit more subtly, with less pomp and circumstance.There were, of course, the headline makers: Stryker Corp.’s $5.4 billion bid for Wright Medical Group (still pending, by the way), Johnson & Johnson’s consummation of Auris Health (a $3.4 billion marriage), Colfax Corporation’s official integration of DJO Global Inc. ($3.15 billion in cash well spent), and Stryker’s takeover of both Mobius Imaging and GYS Tech. Yet, for every Stryker-Wright or Colfax-DJO deal, there were dozens of unions that flew under the radar last year. DePuy Synthes, for instance, hooked up with Zebra Medical Vision in January, Smith+Nephew plc paired itself with Osiris Therapeutics in March, and Globus Medical Inc. purchased large-joint implant manufacturer StelKast in September.

Many deals reflected the industry’s affinity for robotics. Mobius Imaging complements Stryker’s implant and navigation products, and also supports the Spine division’s foray into the intra-operative imaging market. Smith+Nephew, meanwhile, intends to use Atracsys Sarl’s optical tracking camera fusionTrack 500 in its next-generation robotics platform. Compared to existing tracking technology, fusionTrack 500 is said to offer a better measurement speed and latency performance, reduced procedure times, and increased accuracy for finer surgical tasks such as bone cuts. Smith+Nephew also bought Brainlab’s orthopedic joint reconstruction business last spring to bolster its multi-asset digital surgery and robotic technologies offerings. “This partnership with Brainlab is a critical driver of our digital surgery and robotic ecosystem,” Namal Nawana, former Smith+Nephew CEO, said of the deal.

We hope you enjoy reading this year’s Top 10 report.

Editors’ note: As you read our report, please take note that while the companies are ranked according to sales reported for their most recent fiscal year, some may include non-device sales within a division, such as combination products, drug delivery, software, or device-related services. Not all companies explicitly break out the device portion of total revenues. We consulted numerous public documents and contacted company officials as needed to arrive at the best estimates.

TOP ORTHOPEDIC DEVICE FIRMS

1. Stryker	$14.88B
2. DePuy Synthes	$8.84B
3. Zimmer Biomet	$7.98B
4. Smith & Nephew	$5.13B
5. Medtronic Spine	$2.50B
6. NuVasive	$1.17B
7. DJO	$1.08B
8. Globus Medical	$785M
9. Össur	$686M
10. Integra LifeSciences	$521M